Nigeria Pharmaceuticals and Healthcare Report Q3 2009

Table of Contents

Executive Summary 7
SWOT Analysis8
Nigeria Pharmaceuticals And Healthcare Industry SWOT 8
Nigeria Political SWOT 9
Nigeria Economic SWOT 10
Nigeria Business Environment SWOT 11
Pharmaceutical Business Environment Ratings 12
Table: Middle East And Africa (MEA) - Regional Pharmaceutical Business Environment Ratings for Q309 12
Limits To Potential Returns 13
Risks To Realisation Of Returns 13
Nigeria - Market Summary15
Regulatory Regime16
Import Regime 17
Recent Regulatory Developments 17
Intellectual Property Regime 18
Counterfeit Drugs 19
Recent Developments in Regards to Counterfeit Drugs 21
Pricing And Reimbursement Regime 23
Industry Developments24
Epidemiology 24
Table: Leading Causes Of Death In Africa, 2002 24
Maternal and Child Health 25
Communicable Diseases 26
HIV/AIDS 27
Recent Infectious Diseases Developments 29
Healthcare Sector 29
Healthcare Financing 30
Healthcare Provision 31
Recent Healthcare Sector Developments 31
Healthcare Reforms 33
Health Insurance 34
Traditional African Medicine 36
Domestic Pharmaceutical Sector 37
Recent Domestic Company Developments 38
Foreign Pharmaceutical Sector 40
National Drug Policy 42
Research and Development 44
Medical Devices 45
Recent Developments In The Medical Devices Market 46
Table: Nigeria Free Zones: Key Incentives 46
Industry Forecast Scenario 48
Overall Market Forecasts 48
Table: Nigeria - Drug Market Expenditure Indicators, Historical Data and Forecasts 49
Key Growth Factors - Industry 50
Table: Nigeria - Health Expenditure Indicators, Historical Data and Forecasts 51
Key Growth Factors - Macroeconomic 52
Table: Nigeria - Economic Activity, 2006 - 2013 54
Prescription Drug Market Forecast 55
Table: Nigeria' s Prescription Drug Market Indicators, Historical Data and Forecasts (US$mn unless otherwise stated) 56
Patented Drug Market Forecast 57
Table: Nigeria - Patented Drug Market Indicators, Historical Data and Forecasts, 2003-2013 57
Generic Drug Market Forecast 58
Table: Nigeria - Generic Drug Market Indicators, Historical Data and Forecasts, 2003-2013 58
OTC Drug Market Forecast 59
Table: Nigeria - OTC Market Data Indicators, Historical Data and Forecasts (NGNmn unless otherwise stated) 60
Table: Nigeria - Pharmaceutical Trade Indicators, Historical Data and Forecasts (US$mn), 2003-2013 62
Other Healthcare Data Forecasts 63
Table: Nigeria - Other Health Indicators, Historical Data and Forecasts 63
Key Risks To BMI' s Forecasts 64
Competitive Landscape65
Company Monitor66
Multinational Company Profiles 66
Pfizer 66
Novartis 69
Sanofi-Aventis 70
GlaxoSmithKline (GSK) 71
Merck & Co 72
Indigenous Producers 73
Nigeria-German Chemicals PLC (NGC) 73
Emzor 75
Fidson Healthcare 77
Archy 79
Neros Pharmaceuticals 80
Drugfield Pharmaceuticals Limited 81
Neimeth 82
BMI Forecast Modelling 84
How We Generate Our Pharmaceutical Industry Forecasts 84
Country Snapshot: Nigeria Demographic Data85
Section 1: Population 85
Table: Demographic Indicators, 2005-2030 85
Table: Rural/Urban Breakdown, 2005-2030 86
Section 2: Education And Healthcare 86
Table: Education, 2002-2005 86
Table: Vital Statistics, 2005-2030 86
Section 3: Labour Market And Spending Power 87
Table: Consumer Expenditure, 2000-2012 (US$) 87
Pharmaceutical Business Environment Ratings Methodology 87
Ratings Overview 88
Table: Pharmaceutical Business Environment Indicators 89
Weighting 90
Table: Weighting Of Components 90
Sources 90